LY011

BIOLOGICAL2 trials

Sponsors

Shanghai Longyao Biotechnology Inc., Ltd.

Conditions

Advanced Gastric AdenocarcinomaPancreatic Cancer

Early Phase 1

Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer

Shanghai Longyao Biotechnology Inc., Ltd.Pancreatic Cancer

Start: 2021-08-01End: 2024-08-01Target: 30Updated: 2021-07-19

A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma

Shanghai Longyao Biotechnology Inc., Ltd.Advanced Gastric Adenocarcinoma

Start: 2021-11-01End: 2024-11-01Target: 18Updated: 2021-07-26